Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Q2 Organic Revs Rise 8 Percent, Though Receipts Slide for Second Consecutive Sequential Period

Bruker's revenues have slid for two consecutive periods, not three, as was originally reported.

 

NEW YORK, Aug. 3 (GenomeWeb News) - Bruker BioSciences today said that second-quarter revenue increased 11.3 percent to $71.4 million. The growth included a 3.3 percent favorable currency effect.

 

Despite the year-over-year improvement, the Q2 sales represent the third consecutive sequential quarter in which revenues have fallen. Bruker had fourth quarter 2004 revenue of $85.8 million and first quarter 2005 revenue of $74.9 million.

 

Second-quarter sales in the firm's Bruker Daltonics business, which derives roughly 70 percent of its revenue from life science mass spectrometry systems, grew 7.1 percent to $37.4 million. Sales from Bruker's AXS business, which makes X-ray analysis equipment, swelled 16.4 percent to $34.1 million.

 

The firm's R&D spending rose to $11 million from $10.3 million year over year.

 

Bruker posted second-quarter net earnings of $300,000, or $0 per share, from a net loss of $4.4 million, or $.05 per share, in the same period last year.

 

As of June 30, Bruker listed cash and short-term investments of $92 million.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.